Format

Send to

Choose Destination
CA Cancer J Clin. 2002 May-Jun;52(3):154-79.

The current state of hormonal therapy for prostate cancer.

Author information

1
Division of Hematology and Oncology, University of Michigan Medical Center, Ann Arbor, USA.

Abstract

Androgen deprivation therapy remains a mainstay of treatment for men with prostate cancer. New uses for hormonal therapy, including use in the adjuvant and neoadjuvant setting, are being evaluated. Prevention of the side effects of therapy has led to the development of alternative schedules and therapeutics.

Summary for patients in

PMID:
12018929
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center